LDL‐Cholesterol Is the Only Clinically Relevant Biomarker for Atherosclerotic Cardiovascular Disease (ASCVD) Risk (Englisch)
- Neue Suche nach: Ofori‐Asenso, Richard
- Neue Suche nach: Zoungas, Sophia
- Neue Suche nach: Tonkin, Andrew
- Neue Suche nach: Liew, Danny
- Neue Suche nach: Ofori‐Asenso, Richard
- Neue Suche nach: Zoungas, Sophia
- Neue Suche nach: Tonkin, Andrew
- Neue Suche nach: Liew, Danny
In:
Clinical Pharmacology & Therapeutics
;
104
, 2
;
235-238
;
2018
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:LDL‐Cholesterol Is the Only Clinically Relevant Biomarker for Atherosclerotic Cardiovascular Disease (ASCVD) Risk
-
Beteiligte:Ofori‐Asenso, Richard ( Autor:in ) / Zoungas, Sophia ( Autor:in ) / Tonkin, Andrew ( Autor:in ) / Liew, Danny ( Autor:in )
-
Erschienen in:Clinical Pharmacology & Therapeutics ; 104, 2 ; 235-238
-
Verlag:
-
Erscheinungsdatum:01.08.2018
-
Format / Umfang:4 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Datenquelle:
Inhaltsverzeichnis – Band 104, Ausgabe 2
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 211
-
Issue Information| 2018
- 219
-
In This Issue| 2018
- 220
-
Lipid Lowering Therapy for Atherosclerotic Cardiovascular Disease: It Is Not So SimpleVincent, John et al. | 2018
- 225
-
Highlights| 2018
- 227
-
ASCPT News| 2018
- 232
-
LDL‐Cholesterol Is Not the Only Clinically Relevant Biomarker for Coronary Artery Disease or Acute Coronary SyndromeField, Patrick A. / Vasan, Ramachandran S. et al. | 2018
- 235
-
LDL‐Cholesterol Is the Only Clinically Relevant Biomarker for Atherosclerotic Cardiovascular Disease (ASCVD) RiskOfori‐Asenso, Richard / Zoungas, Sophia / Tonkin, Andrew / Liew, Danny et al. | 2018
- 239
-
Real‐World Evidence: What It Is and What It Can Tell Us According to the International Society for Pharmacoepidemiology (ISPE) Comparative Effectiveness Research (CER) Special Interest Group (SIG)Yuan, Hongbo / Ali, M. Sanni / Brouwer, Emily S. / Girman, Cynthia J. / Guo, Jeff J. / Lund, Jennifer L. / Patorno, Elisabetta / Slaughter, Jonathan L. / Wen, Xuerong / Bennett, Dimitri et al. | 2018
- 242
-
The Education of Prescribers for Safe and Effective Use of MedicationsKorth‐Bradley, Joan M. et al. | 2018
- 244
-
Lipids, Apolipoproteins, and Inflammatory Biomarkers of Cardiovascular Risk: What Have We Learned?Rhainds, David / Brodeur, Mathieu R. / Tardif, Jean‐Claude et al. | 2018
- 257
-
Therapeutic Agents Targeting Cardiometabolic Risk for Preventing and Treating Atherosclerotic Cardiovascular DiseasesArsenault, Benoit J. / Perrot, Nicolas / Puri, Rishi et al. | 2018
- 269
-
Clinical Lipidology and the Prevention of Vascular Disease: Time for Personalized TherapyBrown, William Virgil et al. | 2018
- 282
-
Considerations for Developing Targeted Therapies in Low‐Frequency Molecular Subsets of a DiseaseSchuck, Robert N. / Woodcock, Janet / Zineh, Issam / Stein, Peter / Jarow, Jonathan / Temple, Robert / Permutt, Thomas / LaVange, Lisa / Beaver, Julia A. / Charlab, Rosane et al. | 2018
- 290
-
Lowering LDL‐Cholesterol and CV Benefits: Is There a Limit to How Low LDL‐C Needs to be for Optimal Health Benefits?Vani, Anish / Underberg, James A. et al. | 2018
- 297
-
CETP‐Inhibition and HDL‐Cholesterol: A Story of CV Risk or CV Benefit, or BothNicholls, Stephen J. et al. | 2018
- 301
-
Underuse of Vitamin K Antagonist and Direct Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A Contemporary ReviewHsu, Jonathan C. / Freeman, James V. et al. | 2018
- 311
-
A Rapid (Differential) Effect of Rosuvastatin and Atorvastatin on High‐Sensitivity Cardiac Troponin‐I in Subjects With Stable Cardiovascular DiseaseBodde, Mathijs C. / Welsh, Paul / Bergheanu, Sandrin C. / Lijfering, Willem M. / Mertens, Bart / Liem, An‐Ho / van der Laarse, Arnoud / Sattar, Naveed / Jukema, J. Wouter et al. | 2018
- 317
-
Key Learning Outcomes for Clinical Pharmacology and Therapeutics Education in Europe: A Modified Delphi StudyBrinkman, David J. / Tichelaar, Jelle / Mokkink, Lidwine B. / Christiaens, Thierry / Likic, Robert / Maciulaitis, Romaldas / Costa, Joao / Sanz, Emilio J. / Maxwell, Simon R. / Richir, Milan C. et al. | 2018
- 326
-
Antituberculosis Drug‐Induced Adverse Events in the Liver, Kidneys, and Blood: Clinical Profiles and Pharmacogenetic PredictorsHu, Xuejiao / Zhang, Mei / Bai, Hao / Wu, Lijuan / Chen, Yanqing / Ding, Liu / Zhao, Zhenzhen / Peng, Wu / Liu, Tangyuheng / Song, Jiajia et al. | 2018
- 335
-
First‐in‐Human Study With the Inhaled TLR9 Oligonucleotide Agonist AZD1419 Results in Interferon Responses in the Lung, and Is Safe and Well‐ToleratedJackson, Sam / Candia, Albert F. / Delaney, Stephen / Floettmann, Simone / Wong, Clifford / Campbell, John D. / Kell, Sariah / Lum, Jeremy / Hessel, Edith M. / Traquina, Paula et al. | 2018
- 346
-
Real‐Life Use of Neurohormonal Antagonists and Loop Diuretics in Chronic Heart Failure: Analysis of Serial Biomarker Measurements and Clinical OutcomeBrankovic, Milos / Akkerhuis, K. Martijn / van Boven, Nick / Manintveld, Olivier / Germans, Tjeerd / Brugts, Jasper / Caliskan, Kadir / Umans, Victor / Constantinescu, Alina / Kardys, Isabella et al. | 2018
- 356
-
Comparison of Two Highly Automated ECG Algorithms for Detection of Drug‐Induced Cardiac Ion Channel BlockBrockway, Marina / Fossa, Anthony A. / Mason, Jay W. et al. | 2018
- 364
-
Pharmacokinetics, Pharmacodynamics, and Proposed Dosing of the Oral JAK1 and JAK2 Inhibitor Baricitinib in Pediatric and Young Adult CANDLE and SAVI PatientsKim, Hanna / Brooks, Kristina M. / Tang, Cheng Cai / Wakim, Paul / Blake, Mary / Brooks, Stephen R. / Montealegre Sanchez, Gina A. / de Jesus, Adriana A. / Huang, Yan / Tsai, Wanxia Li et al. | 2018
- 374
-
Ribociclib Bioavailability Is Not Affected by Gastric pH Changes or Food Intake: In Silico and Clinical EvaluationsSamant, Tanay S. / Dhuria, Shyeilla / Lu, Yasong / Laisney, Marc / Yang, Shu / Grandeury, Arnaud / Mueller‐Zsigmondy, Martin / Umehara, Kenichi / Huth, Felix / Miller, Michelle et al. | 2018
- 384
-
Pediatric Development of Molecularly Targeted Oncology DrugsPatel, Shivam Kamlesh / Leong, Ruby / Zhao, Hong / Barone, Amy / Casey, Denise / Liu, Qi / Burckart, Gilbert J. / Reaman, Gregory et al. | 2018
- 390
-
Postmarket Safety Outcomes for New Molecular Entity (NME) Drugs Approved by the Food and Drug Administration Between 2002 and 2014Pinnow, Ellen / Amr, Sania / Bentzen, Søren M. / Brajovic, Sonja / Hungerford, Laura / St. George, Diane Marie / Dal Pan, Gerald et al. | 2018